Coronavirus Energy News

Blood Collection Devices Market Opportunity 2020 to 2027 – Leading players Greiner AG, Sekisui Chemical, Narang Medical Limited, SARSTEDT AG

Blood collection devices help in safe withdrawal of blood. Blood is collected from donor to perform various diagnostic tests. Needles & rings, lancets, and other devices are used for arterial and venous blood collection. Arterial blood collection has various advantages such as arterial blood gas sampling and intraoperative blood salvage. However, with the growing number of accidents & trauma cases, rising incidence of infectious disease, and developing liquid biopsy technology have improved associated healthcare processes. However, the shortage of qualified personnel will impede the market growth. Furthermore, the growth opportunities among emerging nations are likely to offer significant opportunities for the growth of the global blood collection devices market.

The blood collection devices market was valued at US$ 9,060.98 million in 2019 and is projected to reach US$ 14,228.70 million by 2027; it is expected to grow at a CAGR of 5.9% during 2020–2027.

Get sample PDF copy at: https://www.theinsightpartners.com/sample/TIPHE100001279/

Company Profiles

  • BD
  • Terumo Corporation
  • Cardinal Health Inc
  • SARSTEDT AG & Co. KG
  • Nipro
  • Thermo Fisher Scientific Inc.
  • Greiner AG
  • Sekisui Chemical Co. Ltd
  • Narang Medical Limited
  • FL MEDICAL s.r.l

Based on product, the blood collection devices market is segmented into blood collection tubes, blood collection needles/holders, blood collection sets, and others. In 2019, the blood collection needles/holders segment accounted for the largest share of the global blood collection devices market. The growth of the segment attributes to the high adoption of the products in various medical diagnostic and treatment procedures. Moreover, repeat purchases and high affordability are some of the primary factors contributing to the dominance of the segment in the global blood collection devices market.

Traditionally, antimicrobial therapy was used to cure infectious diseases; however, over the years, microbes have developed resistance against drugs, owing to which antimicrobial agents have failed to deliver the coveted results. Despite significant advancements in sanitation and therapy, there are rising cases of infectious diseases, such as human papillomavirus (HPV), hepatitis, human immunodeficiency virus (HIV), tuberculosis, and malaria. This rising prevalence of diseases will be promising for market growth as blood tests are a primary mode of diagnosing these conditions.

A rise in the number of road accidents, fires, and sports injuries has led to an increase in the incidences of trauma and injuries. According to the Global Status Report on Road Safety, a report published by WHO in 2018, approximately 1.3 billion people die in road accidents each year, and is one of the leading causes of mortality worldwide. Current trend analysis predicts that by 2030, road accidents will become the fifth-leading cause of death globally.

Purchase Copy of This Report at: https://www.theinsightpartners.com/buy/TIPHE100001279/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:
Call: +1-646-491-9876
Email: [email protected]